207_Combined course Presentations

Impact of IMRT compared to 3D-CRT: Quality of Life

FACT-LCS decline

 QoL evaluated with the FACT-LCS scale (Fuctional Assessment of Cancer Therapy – Lung Cancer Subscale) at baseline (313 pts), 3 (219 pts) and 12 months (137 pts)  Significantly more patients on 74Gy arm had clinically meaningful decline in FACT-LCS at 3 months than on the 60Gy arm (45% vs. 30%, p=0.02) At 12 months, fewer patients who received IMRT (vs 3DCRT) had clinically meaningful decline in FACT- LCS (21% vs 46%, p=0.003) 

Movsas B. et al., JAMA Oncol 2016;2